News

Several futuristic technologies and their potential impact on healthcare were discussed during the Future of Cardiovascular Medicine track sessions at the American College of Cardiology (ACC) 2015...

The Medicines Company, cangrelor, FDA advisory committee, approval

The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9 - 2 with one abstention to recommend approval of...

Infraredx, LRP Study, TVC Imaging System, Lipid-Rich Plaques, 1,000 patients

Infraredx Inc. announced the enrollment of 1,000 patients in the Lipid-Rich Plaque (LRP) Study. The LRP Study is a prospective, multi-center clinical trial designed to identify a correlation...

Protek Duo, VV ECLS, CE mark, CardiacAssist, veno-venous cannula

CardiacAssist Inc. announced that it received a Class 3 CE-mark for its Protek Duo veno-venous cannula. The Protek Duo is licensed for use as a single cannula for both venous drainage and...

atherosclerosis, vitamin C, heart disease, Dr. Rath Research Institute

Scientific confirmation has just been published in the American Journal of Cardiovascular Disease that atherosclerosis, the underlying process of heart attacks and strokes, is generally...

CSI, Diamondback 360, atherectomy, PAD, Stealth 360

Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) clearance for the 4 French, 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System...

carotid artery stenting, F-EPD, P-EPD, ACC, embolic protection devices

A study published in JACC: Cardiovascular Interventions showed that in-hospital and 30-day stroke or death rates were equally low with either a distal filter embolic protection device (F-...

Contego Medical announced the completion of a $5.6 million Series B financing round, led by Hatteras Venture Partners. Hatteras is an early stage venture firm with a focus on medical devices,...

SCAI, survey, interventional cardiologists, work injury, orthopedic, radiation

Nearly half of interventional cardiologists responding to a survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) reported at least one work-related orthopedic...

intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective

Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic impact of percutaneous ventricular assist devices (pVAD) with intra-aortic balloon pumps (IABP)...

ORSIF, fluoroscopy, interventional, health risks, awareness

A new non-profit association, the Organization for Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), was recently launched to generate awareness of the potential serious health...

expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS) devices for treatment of heart failure....

IMRIS, Visius iCT, Health Canada, licensing

IMRIS Inc. announced that Visius iCT, its ceiling-mounted intraoperative computed tomography scanner, has received Health Canada licensing allowing for sales and marketing in the country.

iFR Scout, pullback software, iFR Modality, fractional flow reserve, FFR

Royal Philips announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software. iFR Scout is a functional extension of its existing instant wave-Free Ratio...

The opening session speakers at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will examine the current state of cardiovascular care and why it is...

hospital, stay, heart attack, angioplasty, study

Patients 65 or older discharged from the hospital as early as 48 hours after angioplasty following a major heart attack have similar outcomes as those who stay four to five days, provided...

Children's Hospital of Michigan, Ariana Smith, aortic aneurysm, 3-D printing

Seventeen-year-old Ariana Smith recently became the first patient at the Children's Hospital of Michigan, and the first in Michigan, to benefit from a revolutionary 3-D printed heart model to...

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia...

Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows...

UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality outcomes. The goal of the study was to uncover several trends related to high-...